JPS52111545A - Process for manufacture of aminoglycoside derivatives and derivatives used therefor - Google Patents

Process for manufacture of aminoglycoside derivatives and derivatives used therefor

Info

Publication number
JPS52111545A
JPS52111545A JP860177A JP860177A JPS52111545A JP S52111545 A JPS52111545 A JP S52111545A JP 860177 A JP860177 A JP 860177A JP 860177 A JP860177 A JP 860177A JP S52111545 A JPS52111545 A JP S52111545A
Authority
JP
Japan
Prior art keywords
derivatives
manufacture
used therefor
aminoglycoside
derivatives used
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP860177A
Other languages
English (en)
Inventor
Kurain Rosu Baarii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of JPS52111545A publication Critical patent/JPS52111545A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/08—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D265/10—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen atoms directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP860177A 1976-02-25 1977-01-28 Process for manufacture of aminoglycoside derivatives and derivatives used therefor Pending JPS52111545A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7529/76A GB1529243A (en) 1976-02-25 1976-02-25 Process for the preparation of aminoglycoside derivatives and cyclic urethane intermediates for use therein

Publications (1)

Publication Number Publication Date
JPS52111545A true JPS52111545A (en) 1977-09-19

Family

ID=9834870

Family Applications (1)

Application Number Title Priority Date Filing Date
JP860177A Pending JPS52111545A (en) 1976-02-25 1977-01-28 Process for manufacture of aminoglycoside derivatives and derivatives used therefor

Country Status (26)

Country Link
US (1) US4107435A (ja)
JP (1) JPS52111545A (ja)
AR (1) AR215616A1 (ja)
AT (1) AT348123B (ja)
BE (1) BE851777A (ja)
CA (1) CA1071624A (ja)
CH (1) CH618706A5 (ja)
CS (2) CS195714B2 (ja)
DD (2) DD135200A5 (ja)
DE (1) DE2708008C3 (ja)
DK (1) DK82177A (ja)
EG (1) EG12650A (ja)
ES (1) ES456304A1 (ja)
FI (1) FI770568A (ja)
FR (2) FR2351109A1 (ja)
GB (1) GB1529243A (ja)
GR (1) GR66424B (ja)
HU (1) HU179565B (ja)
IE (1) IE44885B1 (ja)
LU (1) LU76829A1 (ja)
NL (2) NL166265C (ja)
PL (2) PL103737B1 (ja)
PT (1) PT66229B (ja)
RO (1) RO76081A (ja)
SE (1) SE7702066L (ja)
SU (1) SU659092A3 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5461151A (en) * 1977-10-25 1979-05-17 Shionogi & Co Ltd Novel aminoglycoside derivative
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
US4327087A (en) * 1978-01-16 1982-04-27 Schering Corporation Stabilized Netilmicin formulations
JPS5538345A (en) * 1978-09-11 1980-03-17 Shionogi & Co Ltd Novel aminoglycoside derivative
US4226980A (en) * 1978-12-07 1980-10-07 Abbott Laboratories Novel derivatives of fortimicin B and process for preparing same
DE2924659A1 (de) * 1979-06-19 1981-01-22 Bayer Ag Pseudotrisaccharide, ihre herstellung und verwendung als arzneimittel
DE3000841A1 (de) * 1980-01-11 1981-07-16 Bayer Ag, 5090 Leverkusen Isolierung und reinigung von aminoglycosid-antibiotiaka
DE3101376A1 (de) * 1981-01-17 1982-09-02 Bayer Ag, 5090 Leverkusen Sisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
US7794713B2 (en) 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
WO2009117036A2 (en) * 2007-12-21 2009-09-24 Massachusetts Institute Of Technology Bioactive molecules from co-cultivation of microbes
WO2018005964A1 (en) * 2016-07-01 2018-01-04 Wake Forest University Health Sciences Modified carbohydrates, compositions comprising the same, and methods of making and using the same
US10766970B2 (en) 2016-07-01 2020-09-08 Wake Forest University Health Sciences Modified carbohydrates, compositions comprising the same, and methods of making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2399118A (en) * 1942-02-13 1946-04-23 Mallinckrodt Chemical Works 2-oxazolidone compounds and method for preparing the same
DE1593321A1 (de) * 1962-04-03 1970-04-02 Rit Rech Ind Therapeut Verfahren zur Herstellung von niederen N-Alkylderivaten basischer Antibiotica

Also Published As

Publication number Publication date
ES456304A1 (es) 1978-01-16
DE2708008B2 (de) 1981-07-02
FR2351127B1 (ja) 1981-06-12
CA1071624A (en) 1980-02-12
NL166265B (nl) 1981-02-16
SE7702066L (sv) 1977-08-26
CS195714B2 (en) 1980-02-29
FR2351127A1 (fr) 1977-12-09
RO76081A (ro) 1981-08-17
NL7701980A (nl) 1977-08-29
DK82177A (da) 1977-08-26
DE2708008A1 (de) 1977-09-01
GB1529243A (en) 1978-10-18
FR2351109A1 (fr) 1977-12-09
BE851777A (fr) 1977-08-24
PT66229A (en) 1977-03-01
US4107435A (en) 1978-08-15
IE44885L (en) 1977-08-25
PT66229B (en) 1978-07-17
AR215616A1 (es) 1979-10-31
GR66424B (ja) 1981-03-20
FR2351109B1 (ja) 1981-07-24
HU179565B (en) 1982-11-29
DE2708008C3 (de) 1982-04-22
IE44885B1 (en) 1982-05-05
ATA116777A (de) 1978-06-15
DD130150A5 (de) 1978-03-08
LU76829A1 (ja) 1978-10-18
PL103737B1 (pl) 1979-07-31
EG12650A (en) 1979-06-30
FI770568A (ja) 1977-08-26
CS195715B2 (en) 1980-02-29
DD135200A5 (de) 1979-04-18
PL102193B1 (pl) 1979-03-31
AT348123B (de) 1979-01-25
CH618706A5 (ja) 1980-08-15
NL7901693A (nl) 1979-07-31
NL166265C (nl) 1981-07-15
SU659092A3 (en) 1979-04-25

Similar Documents

Publication Publication Date Title
YU164277A (en) Process for obtaining androstene-17-one derivatives and use thereof
JPS5321134A (en) 44hydroxyphenylalkanolamine derivatives and process for preparation therefor
JPS52111545A (en) Process for manufacture of aminoglycoside derivatives and derivatives used therefor
YU39388B (en) Process for the manufacture of anthracycline antibiotic complex and components thereof: musetamycin and marcelomycin
YU173376A (en) 3-oxime-esters of d-17-ethylene-19-nortestosterone and process for the manufacture thereof
ZA773459B (en) 4-trifluoromethyl-benzoic acid derivatives and process of making the same and pharmaceutical-compositions containing same
JPS535141A (en) New intermediates of aminoglycoside and process for manufacture thereof
PT66498A (en) Process for preparation of new n-phosphonomethylglicine derivatives
JPS5259134A (en) New aminoglycoside derivatives and process for manufacture thereof
GR63697B (en) Process for derivatives preparation of phenyl-alamine
IL51432A (en) Process for preparation of 3-halomethycephems
JPS5337730A (en) Process for manufacture of quinacridone and derivatives thereof
GR63193B (en) Preparation process of thioured derivatives
JPS524536A (en) 22hydroxybenzantron and process for producing substituted derivatives thereof
JPS5287153A (en) Production of indanepentaol derivatives and related compounds
GR63658B (en) Process for derivatives preparation of naphyridine
JPS5283350A (en) Substituted 11alkenyllchclohexanol and chclohexene and process for manufacture thereof
GB1549342A (en) 11-oxo-prostaglandin derivatives and processes for their manufacture
JPS52153945A (en) New toropone derivative and process for manufacture thereof
IL52320A0 (en) P-isobutzyl hydratropate of guyiycol and process for its preparation
JPS52110728A (en) Process for manufacture of 33deoxyanthocycnidin and flavone
IL52488A (en) 9-desacetyl daunoruiin derivatives and process for their preparation
JPS52116441A (en) Prostenic acid* derivatives and process for manufacture thereof
JPS5285145A (en) Process for manufacture of 22halocyclobutanone
JPS532453A (en) Neamin derivatives and process for manufacture thereof